The FGF family: biology, pathophysiology and therapy

Beenken, Andrew, Mohammadi, Moosa·2009·Nature Reviews Drug Discovery

Cited by (1,001)

Items 301–400 of 1,001

  1. Structural Biology of the FGF7 Subfamily
    Allen Zinkle, Moosa Mohammadi · 2019 · Frontiers in Genetics
  2. The 5‐HT2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment
    Bernhard Svejda, Mark S. Kidd, Francesco Giovinazzo, Karim M. Eltawil, Björn Inge Gustafsson, Roswitha Pfragner, Irvin Mark Modlin · 2010 · Cancer
  3. The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study
    Tom D. Bunney, Shunzhou Wan, Nethaji Thiyagarajan, Ludovico Sutto, Sarah V. Williams, Paul Ashford, Hans Koss, Margaret A. Knowles, Francesco Luigi Gervasio, Peter V. Coveney et al. · 2015 · EBioMedicine
  4. The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
    Sen Wang, Yudong Qiu, Bing Bai · 2019 · Frontiers in Oncology
  5. Phase separation on cell surface facilitates bFGF signal transduction with heparan sulphate
    Song Xue, Fan Zhou, Tian Zhao, Huimin Zhao, Xuewei Wang, Long Chen, Jin‐Ping Li, Shizhong Luo, Shizhong Luo · 2022 · Nature Communications
  6. The potential function and clinical application of FGF21 in metabolic diseases
    Zhiwei Chen, Lili Yang, Yang Liu, Ping Huang, Haiyan Song, Peiyong Zheng · 2022 · Frontiers in Pharmacology
  7. Roles of FGFs as Adipokines in Adipose Tissue Development, Remodeling, and Metabolism
    Hiroya Ohta, Nobuyuki Itoh · 2014 · Frontiers in Endocrinology
  8. CRTC1 Nuclear Translocation Following Learning Modulates Memory Strength via Exchange of Chromatin Remodeling Complexes on the Fgf1 Gene
    Shusaku Uchida, Brett J.W. Teubner, Charles Hevi, Kumiko Hara, Ayumi Kobayashi, Rutu M. Dave, Tatsushi Shintaku, Pattaporn Poonsawas, Hirotaka Yamagata, Takayoshi Suzuki et al. · 2017 · Cell Reports
  9. Antiangiogenic Effects of Coumarins against Cancer: From Chemistry to Medicine
    Mohammad Bagher Majnooni, Sajad Fakhri, Antonella Smeriglio, Domenico Trombetta, Courtney R. Croley, Piyali Bhattacharyya, Eduardo Sobarzo‐Sánchez, Mohammad Hosein Farzaei, Anupam Bishayee · 2019 · Molecules
  10. Effects of fibroblast growth factor 21 on the heart
    Tanajak, Pongpan, Chattipakorn, Siriporn C, Chattipakorn, Nipon · 2015 · Journal of Endocrinology
  11. Multi-omics profiling: the way toward precision medicine in metabolic diseases
    Cheng Hu, Weiping Jia · 2021 · Journal of Molecular Cell Biology
  12. Long pentraxin‐3 as an epithelial–stromal fibroblast growth factor‐targeting inhibitor in prostate cancer
    Roberto Ronca, Patrizia Alessi, Daniela Coltrini, Emanuela Di Salle, Arianna Giacomini, Daria Leali, Michela Corsini, Mirella Belleri, Chiara Tobia, Cecília Garlanda et al. · 2013 · The Journal of Pathology
  13. A Dominant-Negative FGF1 Mutant (the R50E Mutant) Suppresses Tumorigenesis and Angiogenesis
    Seiji Mori, Vu Tran, Kyoko Nishikawa, Teruya Kaneda, Yoshinosuke Hamada, Naomasa Kawaguchi, Masaaki Fujita, Yoko K. Takada, Nariaki Matsuura∥, Min Zhao et al. · 2013 · PLoS ONE
  14. Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects
    Ying Lei, Luyao Wang, Kaiwen Guo, Yushu Hou, Na Li, Shuyi Wang, Xingfeng Liu, Qijin Zhao, Jie Zhou, Longwei Zhao et al. · 2021 · Nature Communications
  15. Fibroblast growth factor-based pharmacotherapies for the treatment of obesity-related metabolic complications
    Jin, Leigang, Yang, Ranyao, Geng, Leiluo, Xu, Aimin · 2023 · Annual Review of Pharmacology and Toxicology
  16. Angiogenesis in cancer
    Marina Poettler, Gerald W. Prager · 2011 · Hämostaseologie
  17. Genetics of Isolated Hypogonadotropic Hypogonadism: Role of GnRH Receptor and Other Genes
    Beate Karges, Neulen Joseph, Nicolás de Roux, Wölfram Karges · 2011 · International Journal of Endocrinology
  18. Controlling Destiny through Chemistry: Small-Molecule Regulators of Cell Fate
    Ari J. Firestone, James Chen · 2009 · ACS Chemical Biology
  19. The dose–effect relationship in extracorporeal shock wave therapy: the optimal parameter for extracorporeal shock wave therapy
    Xiongliang Zhang, Xiaoyu Yan, Chunyang Wang, Tingting Tang, Yimin Chai · 2013 · Journal of Surgical Research
  20. Glycosaminoglycan Neutralization in Coagulation Control
    Amélie I. S. Sobczak, Samantha Jane Pitt, Alan James Stewart · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
  21. An Overview of FGF19 and FGF21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity
    Nasim Babaknejad, Hashem Nayeri, Roohullah Hemmati, Somaye Bahrami, Ahmad Esmaillzadeh · 2018 · Hormone and Metabolic Research
  22. Dual roles of endothelial FGF-2–FGFR1–PDGF-BB and perivascular FGF-2–FGFR2–PDGFRβ signaling pathways in tumor vascular remodeling
    Kayoko Hosaka, Yunlong Yang, Masaki Nakamura, Patrik Andersson, Xiaojuan Yang, Yin Zhang, Takahiro Seki, Martin Scherzer, Olivier Dubey, Xinsheng Wang et al. · 2018 · Cell Discovery
  23. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling
    Guoqi Li, Yihui Shao, Hong Chang Guo, Ying Zhi, Bokang Qiao, Ke Ma, Jie Du, Yong Qiang Lai, Yulin Li · 2021 · Cardiovascular Research
  24. Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value
    Alessio Ardizzone, Valentina Bova, Giovanna Casili, Alberto Repici, Marika Lanza, Raffaella Giuffrida, Cristina Colarossi, Marzia Mare, Salvatore Cuzzocrea, Emanuela Esposito et al. · 2023 · Cells
  25. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment
    Ilaria Marech, Christian Leporini, Michele Ammendola, Mariangela Porcelli, Cosmo Damiano Gadaleta, Emilio Russo, Giovambattista De Sarro, Girolamo Ranieri · 2015 · Cancer Letters
  26. Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors
    Giulia Taraboletti, Marco Rusnati, Laura Ragona, Giorgio Colombo · 2010 · Oncotarget
  27. The FGFRL1 Receptor Is Shed from Cell Membranes, Binds Fibroblast Growth Factors (FGFs), and Antagonizes FGF Signaling in Xenopus Embryos*
    Florian Steinberg, L. Zhuang, Michael Beyeler, R. Kälin, P. Mullis, A. Brändli, B. Trueb · 2009 · Journal of Biological Chemistry
  28. Crosstalk between androgen and Wnt/β-catenin leads to changes of wool density in FGF5-knockout sheep
    Rui Zhang, Yan Li, Kun Jia, Xueling Xu, Yao Li, Yue Zhao, Xiaosheng Zhang, Jinlong Zhang, Guoshi Liu, Shoulong Deng et al. · 2020 · Cell Death and Disease
  29. Drug resistance mechanisms and progress in the treatment of EGFR‑mutated lung adenocarcinoma (Review)
    Ruizhu Sun, Zhansheng Hou, Yankui Zhang, Bo Jiang · 2022 · Oncology Letters
  30. Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling
    Agostino Di Ciaula, Leonilde Bonfrate, Jacek Baj, Mohamad Khalil, Gabriella Garruti, Frans Stellaard, Helen H. Wang, David Q.‐H. Wang, Piero Portincasa · 2022 · Nutrients
  31. Fabrication of the FGF1-functionalized sericin hydrogels with cell proliferation activity for biomedical application using genetically engineered Bombyx mori (B. mori) silk
    Feng Wang, Yuancheng Wang, Chi Tian, Sheng Xu, Riyuan Wang, Kai Hou, Wenjing Chen, Ping Zhao, Ling Yu, Zhisong Lu et al. · 2018 · Acta Biomaterialia
  32. Tumor-induced osteomalacia
    Zinan Yin, Juan Du, Fan Yu, Weibo Xia · 2018 · Osteoporosis and Sarcopenia
  33. Fgfr1 regulates development through the combinatorial use of signaling proteins
    J. Richard Brewer, Andrei Molotkov, Pierre Mazot, Renée V. Hoch, Philippe M. Soriano · 2015 · Genes & Development
  34. Fibroblast Growth Factors in Depression
    Zheng Hao Deng, Sheng Deng, Mu-Rong Zhang, Mimi Tang · 2019 · Frontiers in Pharmacology
  35. The role of FGF21 in the pathogenesis of cardiovascular disease
    Ying Zhang, Dan Liu, Xiao-Xue Long, Qi-Chen Fang, Wei-Ping Jia, Hua-Ting Li · 2021 · Chinese Medical Journal
  36. Binding affinity estimation from restrained umbrella sampling simulations
    Vivek Govind Kumar, Adithya Polasa, Shilpi Agrawal, Thallapuranam Krishnaswamy Suresh Kumar, Mahmoud Moradi · 2022 · Nature Computational Science
  37. Sensory nerve niche regulates mesenchymal stem cell homeostasis via FGF/mTOR/autophagy axis
    Fei Pei, Li Ma, Junjun Jing, Jifan Feng, Yuan Yuan, Tingwei Guo, Xia Han, Thach‐Vu Ho, Jie Lei, Jinzhi He et al. · 2023 · Nature Communications
  38. Profile of nintedanib in the treatment of solid tumors: the evidence to date
    Niranjan Awasthi, Roderich Egbert Schwarz · 2015 · OncoTargets and Therapy
  39. Thermo-sensitive hydrogels combined with decellularised matrix deliver bFGF for the functional recovery of rats after a spinal cord injury
    Helin Xu, Fu-Rong Tian, Cui‐Tao Lu, Jie Xu, Zi-Liang Fan, Jingjing Yang, Pian-Pian Chen, Yadong Huang, Jian Xiao, Ying‐Zheng Zhao · 2016 · Scientific Reports
  40. Physiology of FGF15/19
    Stacey A. Jones · 2012 · Advances in experimental medicine and biology
  41. Antiangiogenesis therapy: an update after the first decade
    Sandro De Falco · 2014 · The Korean Journal of Internal Medicine
  42. Pathogenetic Features and Current Management of Glioblastoma
    Hong-My Nguyen, Kirsten Guz-Montgomery, Devin B. Lowe, Dipongkor Saha · 2021 · Cancers
  43. Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer
    F. T. Zahra, M. S. Sajib, Constantinos M Mikelis · 2021 · Cancers
  44. FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K–Akt–mTOR signaling pathway
    Han Dai, Wenjing Hu, Lianying Zhang, Feiyu Jiang, Xiongmin Mao, Gangyi Yang, Ling Li · 2021 · Cell Death and Disease
  45. Radiation countermeasure agents: an update
    Francis J. Dumont, Antoine Le Roux, Pierre L. Bischoff · 2009 · Expert Opinion on Therapeutic Patents
  46. The roles of receptor tyrosine kinases and their ligands in the wound repair process.
    Anna-Katharina Müller, M. Meyer, S. Werner · 2012 · Seminars in Cell and Developmental Biology
  47. The fibroblast growth factor family: involvement in the regulation of folliculogenesis
    Roberta Nogueira Chaves, M.H.T. Matos, José Buratini Junior, J.R. Figueiredo · 2012 · Reproduction Fertility and Development
  48. Antibody-Mediated Activation of FGFR1 Induces FGF23 Production and Hypophosphatemia
    Ai-Luen Wu, Bo Feng, Mark Z. Chen, Ganesh A. Kolumam, Jose Zavala‐Solorio, Shelby K. Wyatt, Vineela D. Gandham, Richard A.D. Carano, Junichiro Sonoda · 2013 · PLoS ONE
  49. The FGF21 Receptor Signaling Complex
    Dawn M. Kilkenny, Jonathan V. Rocheleau · 2016 · Vitamins and hormones
  50. FGF10 Protects Against Renal Ischemia/Reperfusion Injury by Regulating Autophagy and Inflammatory Signaling
    Xiaohua Tan, Hongmei Zhu, Qianyu Tao, Lisha Guo, Tian‐Fang Jiang, Le Xu, Ruo Yang, Xiayu Wei, Jin Wu, Xiaokun Li et al. · 2018 · Frontiers in Genetics
  51. γ-PGA hydrogel loaded with cell-free fat extract promotes the healing of diabetic wounds
    Mengting Yin, Xiangsheng Wang, Ziyou Yu, Yun Wang, Xiansong Wang, Mingwu Deng, Danyang Zhao, Shaowei Ji, Nengqing Jia, Wenjie Zhang · 2020 · Journal of Materials Chemistry B
  52. Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2
    Guangyan Du, Jie Jiang, Qibiao Wu, Nathaniel J. Henning, Katherine A. Donovan, Hong Yue, Jianwei Che, Wenchao Lu, Eric S. Fischer, Nabeel M. Bardeesy et al. · 2021 · Angewandte Chemie International Edition
  53. The Saga of Endocrine FGFs
    Phuc Phan, Bibhuti Ballav Saikia, Shivakumar Sonnaila, Shilpi Agrawal, Zeina Alraawi, Thallapuranam Krishnaswamy Suresh Kumar, Shilpa Iyer · 2021 · Cells
  54. Efficient platform for synthesizing comprehensive heparan sulfate oligosaccharide libraries for decoding glycosaminoglycan–protein interactions
    Lei Wang, Alexander W. Sorum, Bo-Shun Huang, Mallory K. Kern, Guowei Su, Nitin Pawar, Xuefei Huang, Jian Liu, Nicola L. B. Pohl, Linda C. Hsieh‐Wilson · 2023 · Nature Chemistry
  55. DJ-1 promotes angiogenesis and osteogenesis by activating FGF receptor-1 signaling
    Jung‐Min Kim, Hong-In Shin, Sun‐Shin Cha, Chang Sup Lee, Bok Sil Hong, Seyoung Lim, Hyun‐Jun Jang, Jaeyoon John Kim, Yong Ryoul Yang, Yun‐Hee Kim et al. · 2012 · Nature Communications
  56. High Molecular Weight Fibroblast Growth Factor-2 in the Human Heart Is a Potential Target for Prevention of Cardiac Remodeling
    Jon‐Jon Santiago, Leslie J. McNaughton, Navid Koleini, Xin Ma, Brian P. Bestvater, Barbara E. Nickel, Robert R. Fandrich, Jeffrey T. Wigle, Darren H. Freed, Rakesh Christopher Arora et al. · 2014 · PLoS ONE
  57. miR‐381‐3p restrains cervical cancer progression by downregulating FGF7
    Anquan Shang, Cheng Zhou, Ganxia Bian, Wei Chen, Wenying Lu, Weiwei Wang, Dong Li · 2018 · Journal of Cellular Biochemistry
  58. The central fibroblast growth factor receptor/beta klotho system: Comprehensive mapping in Mus musculus and comparisons to nonhuman primate and human samples using an automated in situ hybridization platform
    Karin Hultman, Jarrad M. Scarlett, Arian F. Baquero, Anda M. Cornea, Yu Zhang, Casper Bo Gravesen Salinas, Jenny M. Brown, Gregory J. Morton, Erin J. Whalen, Kevin L. Grove et al. · 2019 · The Journal of Comparative Neurology
  59. FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP‐activated protein kinase–Caspase 6 signal axis
    Lintao Song, Luyao Wang, Yushu Hou, Jie Zhou, Chen Chuchu, Xianxi Ye, Wenliya Dong, Huan Fang Gao, Yi Liu, Guanting Qiao et al. · 2022 · Hepatology
  60. FGFR as potential target in the treatment of squamous non small cell lung cancer
    Marcello Tiseo, Francesco Gelsomino, Roberta R Alfieri, Andrea Cavazzoni, Cecilia Bozzetti, Annamaria De Giorgi, Pier Giorgio Petronini, Andrea Ardizzoni · 2015 · Cancer Treatment Reviews
  61. Suppression of Bmp4 signaling by the zinc-finger repressors Osr1 and Osr2 is required for Wnt/β-catenin-mediated lung specification in Xenopus
    Scott A. Rankin, Alyssa L. Gallas, Ana Neto, José Luis Gómez-Skármeta, Aaron M. Zorn · 2012 · Development
  62. Calorie restriction and Roux‐en‐Y gastric bypass have opposing effects on circulating FGF 21 in morbidly obese subjects
    Mirjam A. Lips, Gerrit H. de Groot, Frits J. Berends, Marinus J. Wiezer, Bart A. van Wagensveld, Dingeman J. Swank, Arijan A. P. M. Luijten, Ko Willems van Dijk, Hanno Pijl, Peter L. M. Jansen et al. · 2014 · Clinical Endocrinology
  63. Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans
    Susan Kralisch, Anke Tönjes, Kerstin Krause, Judit Richter, Ulrike Lössner, Peter Louis Kovacs, Thomas Ebert, Matthias Blüher, Michael Stümvoll, Mathias Faßhauer · 2012 · Journal of Endocrinology
  64. Developments in targeted therapy in melanoma
    Valerie C. Amann, Egle Ramelyte, S. Thurneysen, Rossella Pitocco, Nicoletta F. Jaberg-Bentele, Simone M. Goldinger, Reinhard Dummer, Joanna Mangana · 2016 · European Journal of Surgical Oncology
  65. Biological Significance and Targeting of the FGFR Axis in Cancer
    A. Chioni, R. Grose · 2021 · Cancers
  66. New Role for Kruppel-like Factor 14 as a Transcriptional Activator Involved in the Generation of Signaling Lipids
    Thiago M. de Assuncao, Gwen Alyce Lomberk, Sheng Cao, Usman Yaqoob, Angela Mathison, Douglas Alano Simonetto, Robert C. Huebert, Raul A. Urrutia, Vijay H. Shah · 2014 · Journal of Biological Chemistry
  67. Peripheral signalling involved in energy homeostasis control
    Andoni Lancha, Gema Frühbeck, Javier Gómez‐Ambrosi · 2012 · Nutrition Research Reviews
  68. Wnt/β-catenin interacts with the FGF pathway to promote proliferation and regenerative cell proliferation in the zebrafish lateral line neuromast
    Dongmei Tang, Yingzi He, Wenyan Li, Huawei Li · 2019 · Experimental & Molecular Medicine
  69. The Potential of FGF-2 in Craniofacial Bone Tissue Engineering: A Review
    Anita Novais, E. Chatzopoulou, C. Chaussain, C. Gorin · 2021 · Cells
  70. Synthesis and biological evaluation of a triazole-based library of pyrido[2,3-d]pyrimidines as FGFR3 tyrosine kinase inhibitors
    Laurent Le Corre, Anne‐Lise Girard, Johannes Aubertin, François Radvanyi, Catherine Benoist-Lasselin, Aurélie Jonquoy, Emilie Dambroise, Laurence Legeai‐Mallet, Patricia Busca, Yves Le Merrer · 2010 · Organic & Biomolecular Chemistry
  71. Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16
    Emi Matsumoto, Sayaka Sasaki, Hideyuki Kinoshita, Takuya Kito, H. Ohta, Morichika Konishi, K. Kuwahara, K. Nakao, N. Itoh · 2013 · Genes to Cells
  72. The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour
    Stuart James Smith, Mohammed Diksin, Saachi Chhaya, Shwetha Sairam, Maria de los Angeles Estevez-Cebrero, Ruman Rahman · 2017 · International Journal of Molecular Sciences
  73. Single‐Cell and Spatial Transcriptomics Decodes Wharton's Jelly‐Derived Mesenchymal Stem Cells Heterogeneity and a Subpopulation with Wound Repair Signatures
    Penghong Chen, Shijie Tang, Ming Li, Dezhi Wang, Caixiang Chen, Yiqun Qiu, Zhuoqun Fang, Haoruo Zhang, Hangqi Gao, Haiyan Weng et al. · 2022 · Advanced Science
  74. The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples
    Sophia Harlid, Robin Myte, Bethany R. Van Guelpen · 2017 · Mediators of Inflammation
  75. CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice
    Chengming Fan, Yawen Tang, Meng Zhao, Xi Lou, Daniëlle Pretorius, Philippe Menasché, Wuqiang Zhu, Jianyi Jay Zhang · 2020 · Journal of Molecular and Cellular Cardiology
  76. Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease
    Daniel Jahn, Monika Rau, Heike M. Hermanns, Andreas Geier · 2015 · Cytokine & Growth Factor Reviews
  77. FGF21 Protects Dopaminergic Neurons in Parkinson’s Disease Models Via Repression of Neuroinflammation
    Xingxing Fang, Jinyu Ma, Dengcai Mu, Bing Li, Bolin Lian, Cheng Sun · 2020 · Neurotoxicity Research
  78. GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity
    Jiahan Liu, Rongjun Mao, I Weng Lao, Lin Yu, Qianming Bai, Xiaoyan Zhou, Jian Wang · 2021 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  79. FGF8 promotes colorectal cancer growth and metastasis by activating YAP1
    Rui R Liu, Shan Huang, Yunlong Lei, Tao Zhang, Kui Wang, Bo Liu, Edouard Collins Nice, Rong Xiang, Ke Xie, Jingyi Li et al. · 2014 · Oncotarget
  80. Biliopancreatic limb plays an important role in metabolic improvement after duodenal–jejunal bypass in a rat model of diabetes
    Tomohiro Miyachi, Munenori Nagao, Chikashi Shibata, Yoshiro Kitahara, Naoki Tanaka, Kazuhiro Watanabe, Takahiro Tsuchiya, Fuyuhiko Motoi, Takeshi Naitoh, Michiaki Unno · 2016 · Surgery
  81. Production of Recombinant Pharmaceutical Proteins
    Varsha Gupta, Manjistha Sengupta, Jaya Prakash, Baishnab Charan Tripathy · 2016 · Springer eBooks
  82. Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair
    Yu Zhang, Yan Wang, Ding Zhou, Kai Wang, Xu Wang, Xiang Wang, Yang Jiang, Min Zhao, Rutong Yu, Xiuping Zhou · 2021 · Oncogene
  83. The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors
    Hamidreza Zalpoor, Fatemeh Aziziyan, Mahsa Liaghat, Maryam Bakhtiyari, Abdullatif Akbari, Mohsen Nabi‐Afjadi, Razieh Forghaniesfidvajani, Nima Rezaei · 2022 · Cell Communication and Signaling
  84. Research Advances in Tissue Engineering Materials for Sustained Release of Growth Factors
    Haiyang Zhao, Jiang Wu, Jing-jing Zhu, Zecong Xiao, Chaochao He, Hongxue Shi, Xiaokun Li, Shulin Yang, Jian Xiao · 2015 · BioMed Research International
  85. Age-related Changes in Rat Myocardium Involve Altered Capacities of Glycosaminoglycans to Potentiate Growth Factor Functions and Heparan Sulfate-altered Sulfation
    Minh Bao Huynh, Christophe Morin, Gilles Carpentier, Stéphanie Garcia-Filipe, Sofia Talhas-Perret, Véronique Barbier-Chassefière, Toin H. van Kuppevelt, Isabelle Martelly, Patricia Albanese, Dulce Papy-García · 2012 · Journal of Biological Chemistry
  86. Fibroblast Growth Factors in Neurodevelopment and Psychopathology
    Afke F. Terwisscha van Scheltinga, S C Bakker, René S. Kahn, Martien J. Kas · 2013 · The Neuroscientist
  87. Basic fibroblast growth factor promotes the development of human ovarian early follicles during growth in vitro
    T.-r. Wang, L.-y. Yan, Junhao Yan, Cuilin Lu, X. Xia, Tailang Yin, Xiao-hui Zhu, J.-m. Gao, Ting Ding, W.-h. Hu et al. · 2014 · Human Reproduction
  88. A Place for Precision Medicine in Bladder Cancer: Targeting the Fgfrs
    Erica di Martino, Darren Charles Tomlinson, Sarah V. Williams, Margaret A. Knowles · 2016 · Future Oncology
  89. Double signal amplification strategy for ultrasensitive electrochemical biosensor based on nuclease and quantum dot-DNA nanocomposites in the detection of breast cancer 1 gene mutation
    Bin Yang, Song Zhang, Xueen Fang, Jilie Kong · 2019 · Biosensors and Bioelectronics
  90. FGF Receptor Inhibitors: Role in Cancer Therapy
    Gennaro Daniele, Jesus Corral, Lulama Rhoda Molife, Johann Sebastian De Bono · 2012 · Current Oncology Reports
  91. Mutations in fibroblast growth factor (FGF8) and FGF10 identified in patients with conotruncal defects
    Shuang Zhou, Qingjie Wang, Zhuo Meng, Jiayu Peng, Yue Zhou, Wenting Song, Jian Wang, Sun Chen, Kun Sun · 2020 · Journal of Translational Medicine
  92. Targeting the FGF19–FGFR4 pathway for cholestatic, metabolic, and cancerous diseases
    Xiaokun Li, Weiqin Lu, Alexei Kharitonenkov, Yongde Luo · 2024 · Journal of Internal Medicine
  93. Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance
    Oshadi Edirisinghe, Gaetane Ternier, Zeina Alraawi, Thallapuranam Krishnaswamy Suresh Kumar · 2024 · Biomolecules
  94. Potential for Targeting the Fibroblast Growth Factor Receptors in Breast Cancer
    Nancy E. Hynes, Julien H. Dey · 2010 · Cancer Research
  95. FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis
    Tianli Chen, Hongda Liu, Zengli Liu, Kangshuai Li, Ruixi Qin, Yue Wang, Jialiang Liu, Zhipeng Li, Qinglun Gao, Chang Pan et al. · 2021 · Oncogene
  96. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells
    Seiji Mori, Moe Kodaira, Ayano Ito, Mika Okazaki, Naomasa Kawaguchi, Yoshinosuke Hamada, Yoshikazu Takada, Nariaki Matsuura∥ · 2015 · PLoS ONE
  97. Peroxisomes in Human Health and Disease: Metabolic Pathways, Metabolite Transport, Interplay with Other Organelles and Signal Transduction
    Ronald J. A. Wanders · 2013 · Sub-cellular biochemistry/Subcellular biochemistry
  98. Pten Loss Induces Autocrine FGF Signaling to Promote Skin Tumorigenesis
    Kristina Hertzler-Schaefer, Grinu Mathew, Ally-Khan B. Somani, Sunil S. Tholpady, Madhavi Kadakia, Yiping Chen, Dan F. Spandau, Xin Zhang · 2014 · Cell Reports
  99. Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
    Christine F. Heinzle, Zeynep Erdem, Jakob Paur, Bettina Grasl‐Kraupp, Klaus Holzmann, Michael Grusch, Walter Berger, Brigitte Marian · 2014 · Current Pharmaceutical Design
  100. The integrin-binding defective FGF2 mutants potently suppress FGF2 signalling and angiogenesis
    Seiji Mori, Nobuaki Hatori, Naomasa Kawaguchi, Yoshinosuke Hamada, Tsung‐Chieh Shih, Chun‐Yi Wu, Kit S. Lam, Nariaki Matsuura∥, Hirofumi Yamamoto, Yoko K. Takada et al. · 2017 · Bioscience Reports